Published in J Control Release on January 06, 2017
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results. Nat Med (2011) 7.82
Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm (2008) 7.67
Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett (2006) 5.63
Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm (2008) 3.92
Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res (1994) 3.54
Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors. Ann Oncol (2005) 2.84
In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano (2010) 2.30
Skin toxic effects of polyethylene glycol-coated liposomal doxorubicin. Arch Dermatol (2000) 1.98
Drug-induced skin pigmentation. Epidemiology, diagnosis and treatment. Am J Clin Dermatol (2001) 1.88
Near-infrared fluorescence-guided resection of colorectal liver metastases. Cancer (2013) 1.71
Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils. Nat Nanotechnol (2014) 1.63
Measurement of the penetration depths of red and near infrared light in human "ex vivo" tissues. J Photochem Photobiol B (2000) 1.49
Hand-held spectroscopic device for in vivo and intraoperative tumor detection: contrast enhancement, detection sensitivity, and tissue penetration. Anal Chem (2010) 1.47
Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia ('hand-foot' syndrome). Ann Oncol (2007) 1.44
Expression of multilectin receptors and comparative FITC-dextran uptake by human dendritic cells. Int Immunol (2000) 1.26
A Raman-based endoscopic strategy for multiplexed molecular imaging. Proc Natl Acad Sci U S A (2013) 1.18
A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer. Br J Cancer (2013) 1.12
Toxicology and clinical potential of nanoparticles. Nano Today (2011) 1.05
Raman spectroscopy for medical diagnostics--From in-vitro biofluid assays to in-vivo cancer detection. Adv Drug Deliv Rev (2015) 1.03
Nanoparticle exposure in animals can be visualized in the skin and analysed via skin biopsy. Nat Commun (2014) 0.98
A model of the first pass passage of drugs from i.v. injection site to the heart--parameter estimates for lignocaine in the sheep. Br J Anaesth (1996) 0.95
Dermal microvascular endothelial cells express the 180-kDa macrophage mannose receptor in situ and in vitro. J Immunol (2000) 0.91
Modulatory Role of Surface Coating of Superparamagnetic Iron Oxide Nanoworms in Complement Opsonization and Leukocyte Uptake. ACS Nano (2015) 0.87
Quantification of tumor fluorescence during intraoperative optical cancer imaging. Sci Rep (2015) 0.81